Arvinas Inc (NAS:ARVN)
$ 24.96 0.48 (1.96%) Market Cap: 1.71 Bil Enterprise Value: 486.86 Mil PE Ratio: 0 PB Ratio: 2.85 GF Score: 73/100

Arvinas Inc To Host ESMO Data Presentation Call Transcript

Oct 22, 2023 / 01:00PM GMT

Oct 22, 2023 / 01:00PM GMT
Presentation Call
Oct 22, 2023 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Jeff Boyle
Arvinas, Inc. - VP of IR
* John G. Houston
Arvinas, Inc. - Chairperson, CEO & President
* Ronald A. Peck
Arvinas, Inc. - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Ashiq Alim Mubarack
Citigroup Inc., Research Division - U.S. Mid & Small-Cap Biotechnology Analyst
* Bradley Patrick Canino
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Christopher Liu
Leerink Partners LLC, Research Division - Associate
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
* Eliana Rachel Merle
UBS Investment Bank, Research Division - Analyst
* Michael Werner Schmidt
Guggenheim

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot